LexDanaLexDanabeta
Inventor

Haiying QIN

Inventor
US

Overview

3→
Patents
2022–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07KPeptides27%
A61KPreparations for medical, dental or toiletry purposes18%
G01NInvestigating or analysing materials by determining their chemical or physical properties18%
C12NMicroorganisms or enzymes9%
PatentTitleYear
11,980,640Bicistronic chimeric antigen receptors and their uses202411,834,509Thymic stromal lymphopoietin receptor-specific chimeric antigen receptors and methods using same202311,236,171Human monoclonal antibodies specific for FLT3 and uses thereof2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2024Patents assigned to US HEALTH (3)· patent assignee history
2022–2024Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
US HEALTH32022–2024
Locations
LocationPatentsSpan
US32022–2024